For decades, the medical community has viewed heart disease primarily as a “man’s problem.” This misconception has created a dangerous gap in care, leaving millions of women vulnerable to late diagnoses and inadequate treatment. As a physician and health editor, I have seen how these gender-based assumptions can lead to critical delays in the emergency room and the clinic, often with fatal consequences.
The reality is that cardiovascular diseases (CVD) are a leading cause of death for women globally. In France alone, the impact is staggering: more than 200 women die every day from a cardiovascular disease according to reports from June 2025. Despite this, the symptoms and risks associated with these conditions are frequently underestimated or misattributed to stress or anxiety.
Understanding why cardiovascular diseases are underestimated in women is not just a matter of medical curiosity—it is a public health necessity. When we fail to recognize the specific ways heart disease manifests in women, we increase the risk of mortality and long-term disability. This systemic underestimation is rooted in a combination of historical research gaps, atypical symptom presentation, and a persistent lack of screening.
The scale of the crisis is evident in the data. Cardiovascular diseases are responsible for 30% of annual deaths among women, a figure that is twice as high as all forms of cancer combined per the World Heart Federation. By examining the current landscape of cardiovascular health, You can begin to dismantle the myths that put women’s lives at risk.
The Gender Gap in Diagnosis and Screening
One of the most pressing issues in women’s heart health is the prevalence of late diagnosis. Women are often less likely to be screened for cardiovascular risks compared to men, even when they present with similar risk factors. This lack of proactive screening means that many women only enter the healthcare system when a major cardiac event, such as a myocardial infarction (heart attack) or stroke, has already occurred.
In France, the situation is particularly concerning. More than half of the 140,000 annual deaths linked to cardiovascular diseases involve women, making it their primary cause of mortality as reported in June 2025. Despite being more exposed to certain risks than men, women remain insufficiently screened, leading to a cycle of delayed intervention.
The Ministry of Labor, Health, Solidarity, and Families defines these cardiovascular diseases as a group of disorders affecting the heart and blood vessels. These can lead to acute and chronic complications, including acute coronary syndrome (SCA), myocardial infarction, stroke (AVC), and peripheral artery disease of the lower limbs (AOMI). While global mortality rates for these conditions have dropped since 1980 due to better prevention and technical advances, the decline has not been uniform across genders.
The decrease in mortality is notably less marked among women, particularly those under the age of 55. This suggests that the “one size fits all” approach to cardiovascular prevention—which was largely based on male data—is failing women.
The Rising Risk for Younger Women
Perhaps the most alarming trend in recent years is the increase in heart attacks among younger women. For a long time, cardiovascular disease was viewed as a condition of old age, but the data now shows a shift toward younger demographics.
Hospitalization rates for myocardial infarction have been rising among women under 65 for more than two decades. The Fondation Recherche Cardio-Vasculaire reports a significant shift in timing: today, one in four heart attacks in women occurs before the age of 65, compared to only one in six in 2003 as detailed in June 2025.
This trend highlights a critical failure in early detection and risk management. When a woman in her 40s or 50s experiences chest discomfort or shortness of breath, it is frequently dismissed as a symptom of menopause, stress, or a panic attack. This diagnostic overshadowing prevents women from receiving life-saving interventions during the critical window of a heart attack.
Understanding the Complexity of Symptoms
The “classic” symptoms of a heart attack—such as intense pressure in the center of the chest radiating to the left arm—are often based on male presentations. Women are more likely to experience “atypical” symptoms, which may include:
- Unusual fatigue or exhaustion.
- Shortness of breath.
- Pain in the neck, jaw, or upper back.
- Nausea or indigestion-like feelings.
Given that these symptoms do not fit the traditional textbook definition of a cardiac event, both patients and providers may underestimate the urgency of the situation. This leads to a higher rate of delayed treatment and poorer outcomes for women.
The Intersection of Heart Health and Other Conditions
Cardiovascular health does not exist in a vacuum; it is often intertwined with other medical challenges. A critical area of study is the relationship between cardiovascular health and breast cancer treatments. For women undergoing hormone therapy for breast cancer, adherence to cardiovascular treatments is often closely linked to their adherence to their cancer therapy according to the FRM.
This intersection emphasizes the need for an integrated approach to women’s health. When a woman is treating a primary condition like cancer, her cardiovascular risk must be monitored with equal intensity. The complexity of managing multiple medications and the side effects of hormone therapy can further complicate the management of heart health, making professional oversight essential.
The Role of Public Health Policy
To combat the underestimation of cardiovascular disease in women, public health strategies must shift. This includes:
- Gender-Specific Education: Training healthcare providers to recognize the diverse presentation of symptoms in women.
- Targeted Screening: Implementing screening protocols that account for the increased risk in women under 65.
- Public Awareness Campaigns: Educating women that heart disease is their primary cause of mortality, not a secondary concern.
The World Health Organization (WHO) has noted that since 1980, age-standardized cardiovascular mortality has been divided by three globally. Although, the fact that this progress is slower for women underscores a systemic disparity in how we approach the prevention and treatment of heart disease.
Key Takeaways on Women’s Heart Health
- Primary Cause of Death: In France, cardiovascular disease is the leading cause of mortality for women, with over 200 deaths occurring daily.
- Underestimation: Women are often under-screened and their symptoms are more frequently misdiagnosed than those of men.
- Youth Trend: Heart attacks in women under 65 are increasing, with 25% of female infarcts now occurring in this age group.
- Symptom Variance: Women often present with atypical symptoms, leading to delays in emergency care.
- Global Impact: CVD accounts for 30% of annual female deaths, doubling the mortality rate of all cancers combined.
Addressing the underestimation of cardiovascular diseases in women requires a fundamental shift in medical culture. We must move away from the “male-as-default” model of cardiology and embrace a gender-informed approach to diagnosis and care. Only by recognizing the specific risks and symptoms associated with women’s heart health can we reduce the daily death toll and ensure that every patient, regardless of gender, receives timely and accurate care.
For those seeking more information on cardiovascular risk factors and prevention, official health guidelines from the Ministry of Health and the World Heart Federation provide comprehensive resources on monitoring blood pressure, cholesterol, and overall heart health.
As we continue to refine our understanding of gender-specific medicine, the next critical step is the implementation of standardized screening for women under 65 across primary care networks to catch risks before they become fatal events.
Do you or a loved one have experience with the challenges of diagnosing heart disease in women? Share your thoughts and stories in the comments below to facilitate raise awareness.
Related reading